Can Biotech ETFs Continue Their Impressive Run In 2018? (IBB)

pills-drugs-biotech3
From Zacks: So far, it's been a good year for biotech stocks with the Nasdaq Biotechnology Index soaring 19.6% year to date.
NASDAQ:IBB November 14, 2017 7:09am

Outflows Start To Hit The iShares NASDAQ Biotech ETF (IBB)

pills-drugs-biotech2
Analyst/ETF Trader Paul Weisbruch of Street One Financial brings us his daily fund flows update, which today examines a relatively muted ETF landscape that's seen smallish outflows in biotech and some renewed interest in volatility products ahead of earnings season.
NASDAQ:IBB October 24, 2017 11:46am

Biotech Was The Hottest ETF Sector In The Third Quarter (IBB)

pills-drugs-biotech1
From Zacks: The broader market was pretty eventful in the third quarter. While geopolitical and political concerns were rife, those threats couldn't weigh on the equity market returns.
NASDAQ:IBB October 3, 2017 10:09am

Positive Biotech Sentiment Takes Hold (IBB)

pills-drugs-biotech1
From Buzz Indexes: A common question we field relates to the transmission mechanism of sentiment to the share price: "How long does it take / when will it be reflected?"
NASDAQ:IBB July 6, 2017 2:58pm

More Gains Ahead For The Biotech ETF (IBB)?

pills-drugs-biotech3
From Dana Lyons: Last fall, we laid out the foundation for the current rally in pharmaceutical and biotech stocks; we take stock of those setups and the sectors’ present prospects.
NASDAQ:IBB June 29, 2017 8:55am

iShares NASDAQ Biotechnology Index ETF (IBB) Suddenly Looks Bullish

biotech-white-pills
It has been some time since we last spoke about the Biotech Equity segment in this piece, as the sector was simply not a solid performer through much of 2016 and has only recently come to life here in mid-2017.
NASDAQ:IBB June 26, 2017 11:50am

Analyst: Buy Biotech (IBB) On The Next Pullback

biotech-medical-pills
From David Dutkewych: Three weeks ago, I wrote about money pouring into U.S. stocks, specifically technology stocks. Now, just three weeks later, the high-flying tech sector is writing a different story.
NASDAQ:IBB June 23, 2017 6:51am

What’s Next For Biotech Stocks? (IBB)

biotech-white-pills
From Franklin Templeton Investments: Changing political policies and priorities can impact certain market sectors—for better or worse. Health care costs and prescription drug pricing were hot-button issues in the United States during the 2016 presidential election, and the Trump administration has been pushing forward its own health care agenda.
NASDAQ:IBB June 7, 2017 5:57am

Biotech Firms, NIH Team Up To Stop Trump’s Research Budget Cuts

biotech-medical-pills
The CEOs of several prominent biotech companies joined forces with the head of the National Institutes of Health (NIH) today in Washington to try and convince the White House not to seek major budget reductions for medical research.
NASDAQ:IBB May 8, 2017 4:17pm

Will Biotech Bulls Or Bears Blink First?

leverage bull bear 600X300
From Taki Tsaklanos: Stock market indexes gain around 1 percent on Thursday. The small cap index Russell 2000 rose around of 1.15%, making it the best performing U.S. stock market index of the day.
NASDAQ:IBB April 21, 2017 6:21am

BlackRock: Opportunities Abound In Biotech, Healthcare

biotech-white-pills
From BlackRock: A dynamic of haves versus have-nots means that health care is increasingly all about stock picking. Kate Moore sees opportunities in biotech, medical devices, U.S. managed care and selected big pharma with promising drug pipelines.
NASDAQ:IBB April 3, 2017 7:26am

These Sector ETFs Are Looking Pretty Bearish Right Now

bear-mkt
From David Fabian: I’m normally an optimistic, “glass-half-full” kind of guy. I roll my eyes every time I see a headline decrying the next market crash or cataclysmic event that will cripple the global economy. I’m quick to discern speculation from truths and prefer taking the opposite side of most mainstream assumptions.
NASDAQ:IBB March 23, 2017 6:26am

Have Biotech ETFs Finally Bottomed?

biotech-white-pills
From Zacks: 2016 was a tough year for biotech stocks with the sector facing a lot of criticism for rising drug prices. Although shares did rally post-election in November on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the rally turned out to be short-lived following the President’s views regarding drug pricing.
NASDAQ:IBB March 14, 2017 7:54am

Why The $300 Level Is So Important For The Biotech ETF

biotech-dna
From Taki Tsaklanos: Biotechnology stocks are breaking out. They have been consolidating for nearly 20 months. Investors lost interest...and that is exactly what smart investors, in general, want to see in order to buy a market.
NASDAQ:IBB March 3, 2017 6:13am

This Biotech ETF Looks Primed To Rally Again

biotech-white-pills
The biotech sector has gotten a lot of attention lately both in the financial markets and in Washington. The sector, which was one of the worst performing areas of the market in 2016 posting a loss of more than 20%, has started posting gains again and is looking like the rally may be poised to continue.
NASDAQ:IBB February 20, 2017 6:42am

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories